We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mera Pharmaceuticals Inc (CE) | USOTC:MRPI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 00:00:00 |
Delaware
|
|
333-23460
|
|
04-3683628
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
ITEM 2.01
|
COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS
|
|
Mera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
Dated:
December 18, 2020
|
By:
|
/s/ Charles G. Spaniak, Sr.
|
|
|
Name:
|
Charles
G. Spaniak, Sr.
|
|
|
Title:
|
Chief
Executive Officer and President
|
|
1 Year Mera Pharmaceuticals (CE) Chart |
1 Month Mera Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions